Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Symptomatic Severe Aortic Stenosis

Tundra lists 5 Symptomatic Severe Aortic Stenosis clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT07082426

Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study

Early System Experience with the Abbott Balloon-expandable TAVI System

Gender: All

Ages: 18 Years - Any

Updated: 2026-04-08

1 state

Symptomatic Severe Aortic Stenosis
ACTIVE NOT RECRUITING

NCT07116551

Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis

The purpose of this study is to evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.

Gender: All

Ages: 18 Years - Any

Updated: 2026-02-06

4 states

Symptomatic Severe Aortic Stenosis
RECRUITING

NCT06861361

Surgical vs Transcatheter Aortic Valve Replacement in Young Patients

The study objective is to demonstrate that the clinical outcomes of the Myval balloon-expandable THV series are non-inferior to those of SAVR in patients with symptomatic severe aortic stenosis aged 65 to 75 years.

Gender: All

Ages: 65 Years - 75 Years

Updated: 2025-12-18

Symptomatic Severe Aortic Stenosis
ACTIVE NOT RECRUITING

NCT04011722

Portico Next Generation Approval Study

The purpose of this clinical study is to evaluate the acute safety and effectiveness of the next-generation Navitor (Portico™ NG) Transcatheter Aortic Heart Valve as assessed by the rate of all-cause mortality at 30 days and the rate of moderate or greater paravalvular leak at 30 days in a high or extreme surgical risk patient population to support CE (Conformité Européenne) Mark and FDA approval.

Gender: All

Ages: 18 Years - 100 Years

Updated: 2025-07-31

23 states

Symptomatic Severe Aortic Stenosis
RECRUITING

NCT04788888

Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

Evaluation of TAVR using the NAVITOR valve in a Global Investigation.

Gender: All

Ages: 18 Years - 100 Years

Updated: 2025-04-06

3 states

Symptomatic Severe Aortic Stenosis